Aptinyx
researches, discovers, develops and commercializes novel therapies for the treatment of brain and nervous system disorders... Read moreAptinyx
researches, discovers, develops and commercializes novel therapies for the treatment of brain and nervous system disorders... Read more
President & CEO
Norbert G. Riedel
News
May 09, 2023
Americanbankingnews
Aptinyx: Aptinyx (APTX) Set to Announce Earnings on Wednesday
Mar 31, 2023
Benzinga
Aptinyx: Aptinyx Evaluates Strategic Alternatives For Its Future After Failed Trials, 60% Layoffs
Mar 30, 2023
BioSpace
Aptinyx: Aptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic Alternatives
Mar 30, 2023
Zacks
Aptinyx: Here's Why Aptinyx Inc. (APTX) Is a Great 'Buy the Bottom' Stock Now
Mar 09, 2023
Americanbankingnews
Aptinyx: Aptinyx Inc. (NASDAQ:APTX) to Post Q1 2023 Earnings of ($0.15) Per Share, HC Wainwright Forecasts
Mar 01, 2023
MarketScreener
Aptinyx: Aptinyx : Costs Associated with Exit/Disposal - Form 8-K
Feb 28, 2023
Daily Herald
Aptinyx: Aptinyx dementia drug study has poor outcome
Feb 28, 2023
BioPharma Dive
Aptinyx: Following another trial failure, a brain biotech considers 'strategic alternatives'
Feb 21, 2023
Seeking Alpha
Aptinyx: Aptinyx: Readout Imminent For NYX-458 In Parkinson's Disease Dementia
Jan 31, 2023
Life Care News
Aptinyx: Aptinyx to Present at the SVB Securities Global Biopharma Conference
Aptinyx Competitors
1
2
3
4
5
6
7
8
9
10